PL378334A1 - Kompozycja podłoża hodowlanego, sposób hodowli i sposób produkcji mioblastów, oraz ich zastosowanie - Google Patents
Kompozycja podłoża hodowlanego, sposób hodowli i sposób produkcji mioblastów, oraz ich zastosowanieInfo
- Publication number
- PL378334A1 PL378334A1 PL378334A PL37833403A PL378334A1 PL 378334 A1 PL378334 A1 PL 378334A1 PL 378334 A PL378334 A PL 378334A PL 37833403 A PL37833403 A PL 37833403A PL 378334 A1 PL378334 A1 PL 378334A1
- Authority
- PL
- Poland
- Prior art keywords
- culture
- medium composition
- culture medium
- myoblasts obtained
- culture method
- Prior art date
Links
- 238000012136 culture method Methods 0.000 title 1
- 239000001963 growth medium Substances 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 210000003098 myoblast Anatomy 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0658—Skeletal muscle cells, e.g. myocytes, myotubes, myoblasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/38—Vitamins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/11—Epidermal growth factor [EGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/115—Basic fibroblast growth factor (bFGF, FGF-2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/10—Growth factors
- C12N2501/135—Platelet-derived growth factor [PDGF]
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/33—Insulin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/30—Hormones
- C12N2501/38—Hormones with nuclear receptors
- C12N2501/39—Steroid hormones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2501/00—Active agents used in cell culture processes, e.g. differentation
- C12N2501/70—Enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2509/00—Methods for the dissociation of cells, e.g. specific use of enzymes
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Rheumatology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Neurology (AREA)
- Physical Education & Sports Medicine (AREA)
- Urology & Nephrology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0215827 | 2002-12-13 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL378334A1 true PL378334A1 (pl) | 2006-03-20 |
Family
ID=32524649
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL378334A PL378334A1 (pl) | 2002-12-13 | 2003-12-12 | Kompozycja podłoża hodowlanego, sposób hodowli i sposób produkcji mioblastów, oraz ich zastosowanie |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US20060258003A1 (pl) |
| EP (1) | EP1572988A1 (pl) |
| JP (1) | JP2006509516A (pl) |
| KR (1) | KR20050088118A (pl) |
| CN (1) | CN1723277A (pl) |
| AU (1) | AU2003300585A1 (pl) |
| BR (1) | BR0316757A (pl) |
| CA (1) | CA2509642A1 (pl) |
| IL (1) | IL169115A0 (pl) |
| MX (1) | MXPA05006350A (pl) |
| NO (1) | NO20053357L (pl) |
| NZ (1) | NZ540723A (pl) |
| PL (1) | PL378334A1 (pl) |
| RU (1) | RU2005122030A (pl) |
| WO (1) | WO2004055174A1 (pl) |
| ZA (1) | ZA200505125B (pl) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100679642B1 (ko) * | 2005-11-16 | 2007-02-06 | 주식회사 알앤엘바이오 | 인간 지방조직 유래 다분화능 줄기세포 및 이를 함유하는세포치료제 |
| WO2007144467A1 (en) * | 2006-06-12 | 2007-12-21 | Zora Biosciences Oy | Diagnostic method for myopathy |
| WO2008018450A1 (en) * | 2006-08-08 | 2008-02-14 | National University Corporation Nagoya University | Cell preparation containing multipotential stem cells originating in fat tissue |
| EP1900810A1 (fr) * | 2006-09-15 | 2008-03-19 | Celogos | Methode d'extraction et de selection de cellules |
| US20080208164A1 (en) | 2007-02-28 | 2008-08-28 | Innovacell Biotechnologie Gmbh | Methods for the treatment of anal incontinence |
| US20090042296A1 (en) * | 2007-03-16 | 2009-02-12 | Marie Callahan | Transfection ready eukaryotic cells |
| WO2008157059A1 (en) * | 2007-06-15 | 2008-12-24 | Ethicon, Inc. | Tissue fragment compositions for the treatment of incontinence |
| CN101386836B (zh) * | 2007-09-12 | 2010-11-24 | 北京清大天一科技有限公司 | 动物细胞培养基干粉组合物、培养基组合物及其制备方法 |
| ES2360782B1 (es) | 2009-07-28 | 2012-03-12 | Grifols, S.A. | Medios para cultivo de células de mamíferos que comprenden sobrenadante de etapas del fraccionamiento de Cohn y uso de los mismos. |
| EP2397851B1 (fr) | 2010-06-21 | 2015-01-07 | Centre d'Etude des Cellules Souches | Méthode de sélection des modulateurs de la synthèse de mévalonate en utilisant des cellules dérivées de cellules pluripotentes humaines |
| JP2012029623A (ja) * | 2010-07-30 | 2012-02-16 | Bio Link Inc | 細胞分離用酵素溶液及び細胞分離方法、並びに膵島分離方法 |
| JP2015531230A (ja) * | 2012-09-24 | 2015-11-02 | イノヴァセル ビオテヒノロギー アーゲー | 骨格筋由来細胞についての効力アッセイ |
| US10167448B2 (en) | 2013-12-12 | 2019-01-01 | Samsung Life Public Welfare Foundation | Pharmaceutical composition for treating cerebrovascular diseases, containing stem cell-derived exosome as active ingredient |
| JP6553046B2 (ja) * | 2013-12-18 | 2019-07-31 | シィトーＣｙｔｏｏ | 筋芽細胞の筋管への分化を規格化するための装置および方法 |
| RU2576842C2 (ru) * | 2014-02-28 | 2016-03-10 | Общество С Ограниченной Ответственностью "Витацел" | Способ получения миобластов, использование биоптата десны, препарат миобластов для лечения патологий мышечной ткани и способ его получения |
| EP3120857B1 (en) | 2014-03-18 | 2021-02-17 | Samsung Life Public Welfare Foundation | Compositions for use in treating inflammatory brain disease comprising stem-cell-derived exosomes as an active ingredient |
| AU2015277230A1 (en) | 2014-06-18 | 2017-01-05 | Medimmune, Llc | Cell culture methods and media comprising N-acetylcysteine |
| KR101960497B1 (ko) * | 2016-05-09 | 2019-03-21 | 고려대학교 산학협력단 | 소변 유래 세포 배양용 배지 조성물 |
| CA3070048A1 (en) * | 2017-07-15 | 2019-01-24 | Aleph Farms Ltd. | Cultured meat compositions |
| CA3129450A1 (en) * | 2019-02-13 | 2020-08-20 | Tigenix, S.A.U. | Cryopreservation of stem cells |
| CN112592890A (zh) * | 2020-12-17 | 2021-04-02 | 江南大学 | 一种促进肌肉干细胞增殖的方法 |
| EP4317420A4 (en) * | 2021-03-29 | 2024-11-20 | Hyupsung University Industry-Academic Cooperation Foundation | MEDIUM COMPOSITION FOR CULTIVATION OF MUSCLE STEM CELLS WITH CURCUMIN LONGA, GLYSINE OR INSULIN FOR PROLIFERATION OF MUSCLE STEM CELLS |
| CN114752590B (zh) * | 2022-01-14 | 2023-09-08 | 江南大学 | 一种高效且经济的猪肌肉干细胞的分离方法及其应用 |
| CN117625519B (zh) * | 2022-08-12 | 2025-03-25 | 江南大学 | 促肌肉干细胞体外存活和增殖的无胎牛血清培养基及其应用 |
| CN117925509B (zh) * | 2024-03-25 | 2024-06-11 | 山东三链医疗科技有限公司 | 一种细胞培养替代血清培养液及方法 |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1998059035A2 (en) * | 1997-06-25 | 1998-12-30 | The Goverment Of The United States Of America, Represented By The Secretary, Dept. Of Health And Human Services, National Institutes Of Health | Serum-free cell growth medium |
-
2003
- 2003-12-12 RU RU2005122030/13A patent/RU2005122030A/ru unknown
- 2003-12-12 CA CA002509642A patent/CA2509642A1/fr not_active Abandoned
- 2003-12-12 EP EP03813174A patent/EP1572988A1/fr not_active Withdrawn
- 2003-12-12 JP JP2004559824A patent/JP2006509516A/ja active Pending
- 2003-12-12 US US10/538,655 patent/US20060258003A1/en not_active Abandoned
- 2003-12-12 PL PL378334A patent/PL378334A1/pl not_active Application Discontinuation
- 2003-12-12 BR BR0316757-7A patent/BR0316757A/pt not_active IP Right Cessation
- 2003-12-12 MX MXPA05006350A patent/MXPA05006350A/es not_active Application Discontinuation
- 2003-12-12 WO PCT/FR2003/003691 patent/WO2004055174A1/fr not_active Ceased
- 2003-12-12 AU AU2003300585A patent/AU2003300585A1/en not_active Abandoned
- 2003-12-12 KR KR1020057010749A patent/KR20050088118A/ko not_active Withdrawn
- 2003-12-12 CN CNA2003801054437A patent/CN1723277A/zh active Pending
- 2003-12-12 NZ NZ540723A patent/NZ540723A/en unknown
-
2005
- 2005-06-09 IL IL169115A patent/IL169115A0/en unknown
- 2005-07-11 NO NO20053357A patent/NO20053357L/no not_active Application Discontinuation
-
2006
- 2006-01-24 ZA ZA200505125A patent/ZA200505125B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| NO20053357D0 (no) | 2005-07-11 |
| NO20053357L (no) | 2005-07-11 |
| RU2005122030A (ru) | 2005-12-20 |
| WO2004055174A1 (fr) | 2004-07-01 |
| ZA200505125B (en) | 2006-03-29 |
| KR20050088118A (ko) | 2005-09-01 |
| CA2509642A1 (fr) | 2004-07-01 |
| JP2006509516A (ja) | 2006-03-23 |
| AU2003300585A1 (en) | 2004-07-09 |
| EP1572988A1 (fr) | 2005-09-14 |
| MXPA05006350A (es) | 2006-02-08 |
| CN1723277A (zh) | 2006-01-18 |
| IL169115A0 (en) | 2007-07-04 |
| BR0316757A (pt) | 2005-10-25 |
| US20060258003A1 (en) | 2006-11-16 |
| NZ540723A (en) | 2008-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL169115A0 (en) | Culture medium composition culture method, and myoblasts obtained, and their uses | |
| AU2002337497A1 (en) | Carbon material, production method and use thereof | |
| AU2003274906A1 (en) | Double stranded rna structures and constructs, and methods for generating and using the same | |
| MX256798B (es) | Dispersiones de polimeros en medio organico y composiciones que las comprenden. | |
| AU2002234076A1 (en) | Construction composition, structure, and method | |
| AU2003299612A1 (en) | Compounds, compositions and methods | |
| AU2001280149A1 (en) | Stem cell culture medium and culture method by using the same | |
| AU2003256710A1 (en) | Auto-stimulating cells and method for making and using the same | |
| AU2003236118A1 (en) | An antispastic, analgetic pharmaceutical composition and the preparation method thereof as well as the quality control technique therefor | |
| AU2003265040A1 (en) | Drill rod and method in order to manufacture the same | |
| AU2003247449A1 (en) | Nano-ceramics and method thereof | |
| AU2003289651A1 (en) | Pcr method and application by transnormal low thermo-denaturation temperature | |
| AU2003237332A1 (en) | Anti-relp fusion antibodies, compositions, methods and uses | |
| AU2003250545A1 (en) | Recording apparatus, recording method and recording medium | |
| AU2001234616A1 (en) | Vaccine composition, process and methods | |
| IL159856A0 (en) | Fermentation medium and method | |
| AU2001277742A1 (en) | Solid culture medium and method for preparing the same | |
| AU2003292754A1 (en) | Composition for forming silicon7aluminum film, silicon7aluminum film and method for forming the same | |
| AU2003266402A1 (en) | Medium containing water with increased viscosity, method for production and use thereof | |
| AU2003292099A1 (en) | Iron-nickel-cobalt alloy, method for the production and use thereof | |
| AU2003267993A1 (en) | Monooxygenases, nucleic acids encoding them and methods for making and using them | |
| AU2003302001A1 (en) | Ventilator method, ventilator and memory medium | |
| AU2003264894A1 (en) | Novel method for preparing alpha-glycosylceramides, novel alpha-glycosylceramide derivatives and their uses | |
| AU2003282430A1 (en) | Photocatalyst composition and preparing method thereof | |
| AU2003238720A1 (en) | Method for amplifying rna, and its use in expression profiling |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| REFS | Decisions on refusal to grant patents (taken after the publication of the particulars of the applications) |